Veterinary Medicines

LEVAVERM 100 mg/ml soluție orală pentru bovine, oi, porci și găini

Authorised
  • Levamisole hydrochloride
Download as PDF

Product identification

Medicine name:
LEVAVERM 100 mg/ml soluție orală pentru bovine, oi, porci și găini
Active substance:
  • Levamisole hydrochloride
Target species:
  • Sheep
  • Pig
  • Cattle
  • Chicken (hen)
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Levamisole hydrochloride
    100.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral solution
Withdrawal period by route of administration:
  • Oral use
    • Sheep
      • Meat and offal
        15
        day
    • Pig
      • Meat and offal
        11
        day
    • Cattle
      • Meat and offal
        15
        day
    • Chicken (hen)
      • Meat and offal
        3
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AE01
Legal status of supply:
This information is not available for this product.
Authorisation status:
  • Valid
Authorised in:
  • Romania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Dopharma B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Dopharma B.V.
Responsible authority:
  • Institute For Control Of Biological Products And Veterinary Medicines
Authorisation number:
  • 150364
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Romanian (PDF)
Published on: 1/07/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."